Noroviruses, an important cause of diarrhoea in humans, are genetically diverse. The recent norovirus seasons recorded the emergence of new recombinants of the capsid and polymerase genotypes, with a global dominance of GII.Pe_GII.4 Sydney 2012 and GII.P17_GII.17 in Asian countries. However, the number of papers reporting the distribution of both polymerase and capsid genotypes circulating among children is scarce, with none from Vietnam. This study described both the polymerase and capsid genotypes of noroviruses circulating in Vietnamese children using stool specimens obtained under the World Health Organization rotavirus surveillance programme from 2012 to 2015. Of 350 specimens tested, noroviruses were detected in 90 (28 %) of 319 inpatient specimens and in 9 (29 %) of 31 outpatient specimens. The polymerase and capsid genotype combinations of GII.Pe_GII.4 Sydney 2012 and GII.P21_GII.3 were co-dominant (51 and 24 %, respectively), both of which were recombinants, contributing to a high proportion (87 %) of recombinants among circulating noroviruses. GII.4 variants evolved in the same fashion in Vietnam as in other countries, with amino acid substitutions in the putative variantspecific epitopes of the protruding domain. Unlike neighbouring countries where the predominance of GII.P17_GII.17 was reported, only one GII.P17_GII.17 strain was detected from an outpatient in 2015 in Vietnam. In conclusion, a substantial burden due to norovirus gastroenteritis hospitalizations among Vietnamese children was associated with circulating codominant GII.Pe_GII.4 Sydney 2012 and GII.P21_GII.3 strains. Continued surveillance is necessary to monitor infection caused by GII.4 variants and that of GII.P17_GII.17 noroviruses in paediatric patients in Vietnam.
INTRODUCTION
Noroviruses are the second most important cause of acute gastroenteritis in children [1] . In countries where rotavirus vaccines are incorporated in the infant immunization schedule, a decline has been observed in hospitalizations due to rotavirus gastroenteritis with noroviruses becoming the main cause of severe acute gastroenteritis in children aged less than 5 years [2] [3] [4] [5] .
The norovirus genome comprises a single-stranded, positivesense RNA possessing three ORFs, ORF1, ORF2 and ORF3, which respectively encode non-structural viral proteins including the RNA-dependent RNA polymerase (RdRp), the major capsid protein (VP1) and the minor capsid protein (VP2). Structurally, each VP1 monomer is divided into the shell domain (S) and the protruding domain (P), which is further divided into the P1 sub-domain and the P2 sub-domain. The P2 sub-domain reveals the putative variant-specific epitopes that are recognized by the generated human mAbs (blockade epitopes) [6, 7] and the putative histo-blood group antigen (HBGA) binding sites, which are the presumptive initial binding site in establishing human infection [8, 9] .
The two main driving forces of norovirus genome evolution are accumulation of point mutations and recombination occurring between the ORF1 and ORF2 [10] . Noroviruses are classified into six genogroups (I-VI) based on the phylogenetic clustering of the complete VP1 amino acid sequence. Among these, genogroups I and II frequently infect humans [1] . The genogroup is further divided into genotypes and variants; genotypes are defined based on either the VP1 amino acid sequence divergence (the capsid genotype) or the nucleotide sequence divergence of the RdRp (the polymerase genotype). There are 9 and 22 capsid genotypes reported for GI and GII, respectively, and 14 and 26 polymerase genotypes reported for GI and GII, respectively [11] .
Although noroviruses are genetically and antigenically diverse, a single capsid genotype 4 of genogroup II (GII.4) has been dominant for the past two decades, causing both sporadic cases and outbreaks of norovirus gastroenteritis [12] [13] [14] . The second most common genotype detected among children with norovirus gastroenteritis is GII.3 [13, 14] . It is therefore crucial that, if norovirus vaccine is to be developed, a formulation that protects against the capsid genotypes GII.4 and GII.3 should be prioritized. Indeed, a norovirus vaccine against GII.4 has been under clinical development [15] .
On the other hand, minor genotypes have emerged in parts of the world. These include GII.12 in USA, Brazil, South Africa and China between 2007 , GII.13 in India and Nepal between 2009 and 2010 and in China in 2011 . Also emerging in Japan was GII.14 between 2011 and 2013 as well as GII.21 in India in 2005 and in Bhutan between 2011 .
More recently, during the 2014-2015 epidemic season, there was an increase in the number of reports describing a sudden dominance of a minor capsid genotype GII.17 in Japan, China, Taiwan and Hong Kong, apparently replacing the almost-two-decade-dominant GII.4 genotype [25] [26] [27] [28] [29] [30] [31] . The emergence and increase of the non-GII.4 genotypes may be a challenge against the candidate norovirus vaccines [15] , which target the globally predominant GII.4 noroviruses, as it is not known whether they are cross-protective against non-GII.4 noroviruses.
While the major capsid protein is the primary target of the protective antibodies, recombination resulting in the acquisition of new polymerase genotypes is considered another mechanism of gaining the capacity to establish an efficient human-to-human spread [32] . Thus, it is desirable to characterize both capsid and polymerase genotypes in routine surveillance to better understand the molecular epidemiology of noroviruses, including the prevalence of recombinant strains [33] .
However, papers reporting the distribution of both polymerase and capsid genotypes of noroviruses circulating among children are scarce, and none has so far been reported from Vietnam (Table S1 , available in the online Supplementary Material). We, therefore, conducted this study to obtain insight into the circulating polymerase and capsid genotypes of noroviruses in children less than 5 years of age who were hospitalized for acute gastroenteritis in Vietnam, intending to understand the extent of genetic recombination in noroviruses circulating in the children in Vietnam.
METHODS
As part of an ongoing World Health Organization rotavirus surveillance programme in Vietnam, a total of 6259 specimens were collected from children less than 5 years of age hospitalized for diarrhoea from 2012 to 2015 at three hospitals, namely, the National Hospital of Paediatrics located in Hanoi (north), Ninh Hoa General Hospital and Khanh Hoa General Hospital located in Khanh Hoa (centre). Of these, 350 specimens were selected by systematic random sampling using a norovirus-associated diarrhoea hospitalization rate of 28 % [34] and a lower limit of 95 % confidence interval.
The genomic RNAs were extracted from stool suspensions by using a QIAamp Viral RNA Mini kit (Qiagen); cDNA was synthesized from the extracted RNA by using random hexamers and SuperScript III First-Strand Synthesis System (Invitrogen). Norovirus genogroups I and II were detected by Reverse Transcription-Polymerase Chain Reaction (RT-PCR) using the primers targeting the conserved ORF1-ORF2 junction region (region C) and GoTaq Green Master Mix (Promega). The norovirus capsid genotypes were determined by sequencing the amplicon of region C using BigDye Terminator Cycle Sequencing Ready Reaction Kit, version 3.1 (Applied Biosystems). The polymerase genotypes were determined by amplifying and sequencing the continuous sequence of about 800 nt at the 3¢ end of ORF1 (RdRp sequence) and 300 nt of the N/S region. Representative samples of the GII.4 and GII.17 genotypes were amplified and sequenced for the entire capsid gene (ORF2).
The genotypes were determined using the Norovirus Automated Genotyping Tool online (http://www.rivm.nl/mpf/ norovirus/typingtool/). Genetic and phylogenetic analyses were conducted using MEGA v7.0.14 [35] . Recombination events were identified by SimPlot v. 3.5.1 [36] . Homology modelling was performed for GII.4 Sydney 2012 strains using a fully automated protein structure homology-modelling server, SWISS-MODEL (http://swissmodel.expasy.org/), with the templates of 2obr and 4op7 [37] . Visualization and superposition were performed on NOC 3.01 (noch.sourceforge.net/).
RESULTS

Detection of noroviruses
Out of 350 specimens randomly selected from 6259 specimens, 319 were collected from hospitalized children (i.e. inpatients) of which 90 (28.2 %) were positive for norovirus with yearly variation from 23.4 to 33.0 % ( Table 1) . Only in 2015, samples from outpatients were examined for norovirus and 9 (29.0 %) tested positive. There was no difference in the detection rates between inpatients and outpatients (P<0.46).
Distribution of the capsid and polymerase genotypes of noroviruses All of the 99 noroviruses detected in this study belonged to genogroup II of which 85 (86 %) were genotyped for the VP1 capsid (Table 1) ; GII.4 and GII.3 were the most and second most dominant throughout the study period and accounted for 55 and 22 %, respectively. These genotypes were followed by three GII.6 and two GII.17; one GII.17 was detected from an inpatient in 2012, whereas the other from an outpatient in 2015. Table 2 shows the distribution of the 67 specimens for which both the capsid and polymerase genotypes were determined. Notably, 58 (87 %) possessed discordant polymerase and capsid genotypes; hence, they were inter-genotype recombinants. Specifically, GII.Pe_GII.4 Sydney 2012 (n=34) and GII.P21_GII.3 (n=16) accounted for the majority of the recombinants. GII.P17_GII.17 detected in 2015 was also determined to be recombinant as previously circulating GII.17 strains, which were isolated worldwide by 2012, were found to be accompanied by other polymerase genotypes, i.e. GII.P4, GII.P13 or GII.P16 [38] , and the capsid genotype GII.17 was suggested to evolve by exchanging the RdRp gene through the recombination events [26] . When another subtree of the VP1 gene tree that contained the GII.4 Sydney 2012 variants detected in Vietnam and elsewhere in the world was examined (Fig. 2b) , the Vietnamese strains clustered into three separate lineages/sublineages: the GII.Pe_GII.4 Sydney 2012 sub-lineage consisting of strains detected in 2013 (indicated with squares in Fig. 2b ), the GII.Pe_GII. (Fig. 2b) .
Structural characteristics of the VP1 protein of Vietnamese GII.4 variants Based on analysis of amino acid variations in the P2 domain of different strains of Vietnamese GII.4 Sydney 2012 variants, it was found that variations occurred in the putative variant-specific epitopes (blockade epitopes) A, B, C and D, but no variation occurred in epitope E (Fig. 3a) . Amino acid substitutions occurring at residues adjacent to the antigenicity-determining sites and HBGA-binding sites were observed (Fig. 3a) , and such substitutions resulted in obvious or slight changes in the structure (Fig. 3b) and the electrostatic surface potential of the P dimers. NVN15.706/VNM/2015, caused a structural variation in the blockade epitopes D and E (Fig. 3b) . (Fig. 4b ).
DISCUSSION
In this study, norovirus was detected in 28.2 % of Vietnamese children less than 5 years of age who were hospitalized for acute gastroenteritis from 2012 to 2015. This detection rate was in good agreement with the rates reported in earlier studies in Vietnam [34, 39] average (17 %, [40] . When the detection rate of 28 % was taken together with the incidence rate of diarrhoea hospitalizations (60.8/1000 child years) reported in central Vietnam [41] , the annual incidence rate of norovirus hospitalization was calculated to be 17 per 1000 child years among children less than 5 years of age, suggesting the presence of a high disease burden due to norovirus in Vietnam.
In this study, the detection rates of norovirus in both inpatient and outpatient groups were shown to be similar, which is consistent with results previously reported elsewhere in the world [21, 42, 43] . This observation makes a strong contrast with The putative variant-specific epitope of GII.4 [6, 7, 61] what was found in rotavirus-infected children in which the relative frequency among the inpatient group was twice as high as that among the outpatient group [44] [45] [46] [47] .
While this study confirmed the co-dominance of the GII.4 and GII.3 genotypes in Vietnam similar to earlier studies [39, [48] [49] [50] [51] [52] [53] , it was found that these dominant GII.4 and GII.3 capsid genotypes possessed discordant polymerase genotypes GII.Pe and GII.P21, respectively, leading to a high proportion (87 %) of recombinant noroviruses. The recombinant genotype GII.P21_GII.3 has been reported to be the second most dominant genotype, next to GII. P4_GII.4, worldwide since 2000 [13, 14] . While GII. P12_GII.3 was detected in two patients in this study, it was more frequently detected in China and Japan [13, 54, 55] . Globally, GII.4 Sydney 2012 was reported as the predominant genotype since the end of 2012 [18, 23, 29, 52, 54, 56] , and, as it combined with GII.P4 New Orleans 2009 or GII.
Pe, each combination represents intra-genotype or intergenotype recombinant norovirus, respectively [18, 54] .
The proportion of recombinants was not invariable over the study period, but it abruptly increased from 42 % in 2012 to more than 95 % thereafter ( (31-56 % in 2010-2012 to 100 % in 2013) and South Africa (29-42 % in 2009-2012 to 84 % in 2013) [18, 54] . The high proportion of recombinants was also associated with circulation of other recombinant noroviruses, including GII.P7_GII.6, GII.P16_GII.13 and GII. P17_GII.17, which were reported to be recently emerging genotypes elsewhere in the world [18, 21, 27, 29, 54] . These observations led us to hypothesize that acquiring a new polymerase genotype in addition to a new capsid genotype may be a requirement for any new norovirus strain to emerge and spread in the population. Thus, the importance of genotyping not only capsid but also polymerase genotypes in norovirus surveillance needs to be recognized [11, 33] . [23, 52, 54, 56, 58, 59] , although the dominance of GII.4 Den Haag 2006 was still reported until 2011-2012 in a few countries including China [51, 54, 60] .
Phylogenetic analysis revealed that the sources from which GII.4 strains were introduced in the population might be variable. Our analysis suggested that the origin of the Vietnamese GII.4 Den Haag 2006 strain detected in 2012 was the local strains previously circulating in the country, while the origins of Vietnamese GII.4 Sydney 2012 strains were different.
The accumulation of point mutations in the P2 domain, particularly those within the functional loops of GII.4 Sydney 2012 strains, was shown to cause the emergence of new variants in the population [6, 8] . Among five blockade epitopes A-E, the putative variant-specific epitopes A, D and E are large and important ones of GII.4 variants [6] . Mutations on the residues of epitopes A and D among GII.4 Sydney 2012 strains prevailing worldwide were considered to change the antigenicity of the viruses and to cause the emergence of the viruses in the population [7, 61] . Mutations in or around the HBGA-binding sites that results in negative charge of the P dimers may play a role in expanding the HBGA-binding spectrum of recently circulating GII.4 strains because the regions are mostly negatively charged [9] . Therefore, for Vietnamese GII.4 Sydney 2012 strains, the mutations having occurred in epitope A, the most important neutralization escape determinant, and in epitope D, another important blockage epitope [6] , may cause antigenic variations for GII.4 Sydney 2012 strains in different genetic lineages to overcome the herd protection against the preceding norovirus variants. In addition, the mutations occurring at and around the loops of HBGA-binding sites result in structural changes of the HBGA-binding pockets, which are believed to alter HBGA-binding profiles of GII.4 noroviruses [8] . Thus, it is likely that the GII.4 Sydney 2012 strains may adapt to new populations or expand the range of susceptible populations. Another mechanism may be that capsid genotype GII.4 Sydney 2012 was combined with a new polymerase genotype GII.Pe, creating an evolutionary advantage in producing a diverse pool of progeny viruses from which fitter variants may be selected.
Recently, there have been reports of new GII.P17_GII.17 strains as a major cause of norovirus outbreaks in Japan, China, Taiwan and Hong Kong in 2014 and 2015 as well as sporadic cases in China and Hong Kong [22, [25] [26] [27] [28] [29] 31] . In our study, however, only one GII.P17_GII.17 strain was detected in an outpatient despite the fact that the Vietnamese GII.P17_GII.17 strain belonged to the same sub-cluster as the prevailing GII.P17_GII.17 strains, possessing the profile of HBGA-binding sites identical with the ones of outbreak-causing strains in China and Hong Kong [29] .
Previous reports showed that the infection with the emergent GII.P17_GII.17 was more likely to occur among older children and adults [27, 29-31, 62, 63] . Another report from a study conducted among Italian children hospitalized with acute gastroenteritis between September 2014 and March 2015 showed that GII.17 accounted for only 2 (2.5 %) of 81 norovirus-positive samples [63] . Thus, the emerging GII.P17_GII.17 strains may not be as capable of spreading among infants and young children as they are in older children and adults.
In conclusion, this study showed that norovirus imposed a substantial burden on Vietnamese children aged less than 5 years, with GII.Pe_GII.4 Sydney 2012 variants and GII. P21_GII.3 being co-dominant. GII.4 variants evolved in the same fashion in Vietnam as elsewhere in the world, with amino acid substitutions in the major epitopes of the P domain. Unlike neighbouring countries where emerging GII.P17_GII.17 noroviruses caused outbreaks during the 2014-2015 season, only a single GII.P17_GII.17 strain was detected from an outpatient in 2015. Continued surveillance is necessary to monitor infection caused by GII.4 variants and that of GII.P17_GII.17 noroviruses in paediatric patients in Vietnam. 
